Modified MHC Class II-Associated Invariant Chain Induces Increased Antibody Responses against


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
15 04 2019
Historique:
received: 04 09 2018
accepted: 01 02 2019
pubmed: 6 3 2019
medline: 28 12 2019
entrez: 6 3 2019
Statut: ppublish

Résumé

Adenoviral vectors can induce T and B cell immune responses to Ags encoded in the recombinant vector. The MHC class II invariant chain (Ii) has been used as an adjuvant to enhance T cell responses to tethered Ag encoded in adenoviral vectors. In this study, we modified the Ii adjuvant by insertion of a furin recognition site (Ii-fur) to obtain a secreted version of the Ii. To test the capacity of this adjuvant to enhance immune responses, we recombined vectors to encode

Identifiants

pubmed: 30833346
pii: jimmunol.1801210
doi: 10.4049/jimmunol.1801210
pmc: PMC6452028
doi:

Substances chimiques

Antibodies, Protozoan 0
Histocompatibility Antigens Class II 0
Malaria Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2320-2331

Informations de copyright

Copyright © 2019 by The American Association of Immunologists, Inc.

Références

Biotechnol Bioeng. 2012 Mar;109(3):719-28
pubmed: 22252512
J Control Release. 2002 May 17;81(1-2):155-63
pubmed: 11992688
Mol Ther. 2009 Aug;17(8):1333-9
pubmed: 19513019
J Immunol. 2011 Feb 15;186(4):2355-64
pubmed: 21257961
Eur J Cell Biol. 2006 Jun;85(6):457-67
pubmed: 16542748
J Exp Med. 2003 Jun 2;197(11):1467-76
pubmed: 12782713
Immunity. 1999 Aug;11(2):241-51
pubmed: 10485659
Infect Immun. 2010 Jan;78(1):145-53
pubmed: 19858306
Immunity. 2008 Jun;28(6):847-58
pubmed: 18549802
Mol Ther. 2014 May;22(5):1039-47
pubmed: 24476798
J Virol. 2015 Feb;89(3):1889-99
pubmed: 25428875
Curr Gene Ther. 2011 Aug;11(4):307-20
pubmed: 21453277
Gene Ther. 2001 Mar;8(6):487-93
pubmed: 11313828
J Cell Biol. 1994 Jul;126(2):317-30
pubmed: 8034737
PLoS One. 2014 Jun 19;9(6):e100538
pubmed: 24945248
N Engl J Med. 2014 May 8;370(19):1799-808
pubmed: 24806160
Virology. 1996 May 1;219(1):220-7
pubmed: 8623532
J Gene Med. 2004 Feb;6 Suppl 1:S164-71
pubmed: 14978759
Cell Host Microbe. 2015 Jan 14;17(1):118-29
pubmed: 25482433
J Gen Virol. 2007 Jun;88(Pt 6):1708-16
pubmed: 17485530
Expert Rev Vaccines. 2007 Jun;6(3):347-56
pubmed: 17542750
J Immunol. 1997 Mar 15;158(6):2670-9
pubmed: 9058800
Bull World Health Organ. 2008 Feb;86(2):140-6
pubmed: 18297169
Nature. 1990 Dec 13;348(6302):600-5
pubmed: 2250716
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10335-9
pubmed: 8234295
Nat Med. 2005 Apr;11(4 Suppl):S54-62
pubmed: 15812491
J Virol. 2003 Dec;77(24):13407-11
pubmed: 14645597
Methods Cell Biol. 1994;43 Pt A:161-89
pubmed: 7823861
Mol Ther Methods Clin Dev. 2016 Apr 27;3:16030
pubmed: 27162933
Virology. 2000 Apr 25;270(1):146-61
pubmed: 10772987
Malar J. 2008 Jun 12;7:108
pubmed: 18549480
Immunology. 2004 May;112(1):126-33
pubmed: 15129672
Sci Rep. 2016 Jan 08;6:18848
pubmed: 26743316
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11671-5
pubmed: 8524826
Trop Med Int Health. 2002 May;7(5):471-6
pubmed: 12000658
Infect Immun. 2018 Oct 25;86(11):
pubmed: 30150256
J Cell Sci. 1994 Jul;107 ( Pt 7):2021-32
pubmed: 7983165
J Immunol. 1999 Sep 1;163(5):2704-12
pubmed: 10453012
Vaccine. 2017 Feb 22;35(8):1140-1147
pubmed: 28131394
Expert Rev Vaccines. 2011 Sep;10(9):1307-19
pubmed: 21919620
J Immunol. 2008 Mar 1;180(5):3339-46
pubmed: 18292559
Nat Rev Mol Cell Biol. 2002 Oct;3(10):753-66
pubmed: 12360192
Clin Exp Vaccine Res. 2013 Jul;2(2):97-105
pubmed: 23858400
Vaccine. 2016 Apr 19;34(18):2147-56
pubmed: 27004934
Virology. 2007 Oct 10;367(1):156-67
pubmed: 17590405
Vaccine. 2013 Jul 11;31(32):3236-43
pubmed: 23707160
PLoS One. 2012;7(11):e50139
pubmed: 23189185
Cell. 1990 Nov 16;63(4):707-16
pubmed: 2121367
Nat Commun. 2018 Jul 13;9(1):2714
pubmed: 30006528
Curr Opin Immunol. 2011 Jun;23(3):377-82
pubmed: 21514130
Mol Ther. 2006 Feb;13(2):310-9
pubmed: 16275163
EMBO Mol Med. 2016 Aug 01;8(8):839-50
pubmed: 27354391
Cell. 1996 Feb 23;84(4):505-7
pubmed: 8598037
Science. 2015 Jul 17;349(6245):320-4
pubmed: 26138104
PLoS One. 2006 Dec 27;1:e135
pubmed: 17205139
PLoS One. 2016 Jun 23;11(6):e0157066
pubmed: 27336786
J Biol Chem. 1999 Dec 17;274(51):36153-8
pubmed: 10593899
J Cell Sci. 1993 Nov;106 ( Pt 3):831-46
pubmed: 8308066
Nature. 2013 Jun 27;498(7455):502-5
pubmed: 23739325
Expert Opin Biol Ther. 2008 Sep;8(9):1347-63
pubmed: 18694354
EBioMedicine. 2017 Apr;18:204-215
pubmed: 28302457
Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1269-81
pubmed: 27033518
J Gen Virol. 2009 Feb;90(Pt 2):414-422
pubmed: 19141451
J Virol. 1996 Jul;70(7):4805-10
pubmed: 8676512

Auteurs

Cyrielle Fougeroux (C)

Center for Medical Parasitology, Department of International Health, Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark; and cyrielle@sund.ku.dk.

Louise Turner (L)

Center for Medical Parasitology, Department of International Health, Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark; and.

Anders Miki Bojesen (AM)

Department of Veterinary and Animal Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark.

Thomas Lavstsen (T)

Center for Medical Parasitology, Department of International Health, Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark; and.

Peter Johannes Holst (PJ)

Center for Medical Parasitology, Department of International Health, Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH